| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3126545
Max Phase: Preclinical
Molecular Formula: C18H23N3O5
Molecular Weight: 361.40
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCN(C(=O)Nc1cc(C)on1)c1ccc(OC(C)(C)C(=O)O)cc1
Standard InChI: InChI=1S/C18H23N3O5/c1-5-10-21(17(24)19-15-11-12(2)26-20-15)13-6-8-14(9-7-13)25-18(3,4)16(22)23/h6-9,11H,5,10H2,1-4H3,(H,22,23)(H,19,20,24)
Standard InChI Key: PJIQWIFSBIZVSV-UHFFFAOYSA-N
Associated Targets(Human)
Hexokinase type IV 3191 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 361.40 | Molecular Weight (Monoisotopic): 361.1638 | AlogP: 3.67 | #Rotatable Bonds: 7 |
| Polar Surface Area: 104.90 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.37 | CX Basic pKa: | CX LogP: 3.34 | CX LogD: -0.12 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.78 | Np Likeness Score: -1.67 |
References
| 1. Li Y, Tian K, Qin A, Zhang L, Huo L, Lei L, Shen Z, Song H, Feng Z.. (2014) Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPARγ., 76 [PMID:24583379] [10.1016/j.ejmech.2014.02.024] |
Source
Source(1):